Laurus Labs (LAURUSLABS) | Stock Overview & Key Data
Laurus Labs Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,457.00 on June 8, 2026
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Laurus Labs
LAURUSLABS
|
609.64B Large-cap | -1.11% | 4.95% | 44.58% | 38.23% | 25.10% | 109.17% | 278.94% | 134.91% | 1,365.68% | 1,365.68% | 1,365.68% |
|
Sun Pharmaceutical
SUNPHARMA
|
3.88T Large-cap | 0.96% | -3.84% | 1.28% | 0.50% | 4.93% | 7.10% | 82.23% | 170.41% | 143.23% | 656.74% | 2,541.29% |
|
Divi's Laboratories
DIVISLAB
|
1.69T Large-cap | 1.34% | -2.25% | 8.85% | 4.11% | 4.17% | -0.43% | 85.44% | 58.15% | 496.33% | 1,610.60% | 10,946.76% |
|
Torrent
TORNTPHARM
|
1.39T Large-cap | 2.12% | 2.23% | 5.56% | 19.07% | 17.04% | 40.54% | 146.00% | 215.51% | 578.42% | 2,737.14% | 10,046.95% |
|
Dr. Reddy's
DRREDDY
|
1.10T Large-cap | 0.31% | -4.28% | 0.20% | -0.09% | 2.08% | -6.39% | 29.74% | 20.69% | 112.36% | 310.53% | 902.28% |
|
Lupin
LUPIN
|
1.07T Large-cap | 0.83% | -0.14% | -0.76% | 8.63% | 8.10% | 14.69% | 176.15% | 98.45% | 56.65% | 418.49% | 2,332.69% |
Ownership & Short Interest
Calculate Your Laurus Labs Investment Returns
Long-Term Investment Performance Analysis
Laurus Labs stock price in Dec 2016 was ₹95.13, A ₹1,000.00 lump sum investment in Laurus Labs made 9 years ago would be worth approximately ₹14,602.12 today, representing a exceptional return of 1,360.21%. This translates to an annualized return (CAGR) of 32.66%.
9 Years 5 Months Investment Scenario (Dec 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is LAURUSLABS's 52-week high and low?
- In the last 52 weeks, Laurus Labs reached a high of ₹1,457.00 (on June 8, 2026) and a low of ₹641.05 (on June 20, 2025).
- What is the market cap and P/E ratio for LAURUSLABS?
- Curious about Laurus Labs's size and valuation? Its market capitalization stands at 609.64B. When it comes to valuation, the P/E ratio (trailing twelve months) is 70.26, and the forward P/E (looking ahead) is 58.80.
- Does LAURUSLABS pay dividends? If so, what's the yield?
- Yes, Laurus Labs is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.21%, and the company has paid an average of ₹1.60 per share annually over the past 3 years.
- Who are Laurus Labs's main competitors or similar companies to consider before investing?
When looking at Laurus Labs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.88T Healthcare Drug Manufacturers - Specialty & Generic 7.10% 82.23% Divi's Laboratories
DIVISLAB1.69T Healthcare Drug Manufacturers - Specialty & Generic -0.43% 85.44% Torrent
TORNTPHARM1.39T Healthcare Drug Manufacturers - Specialty & Generic 40.54% 146.00% Dr. Reddy's
DRREDDY1.10T Healthcare Drug Manufacturers - Specialty & Generic -6.39% 29.74% Lupin
LUPIN1.07T Healthcare Drug Manufacturers - Specialty & Generic 14.69% 176.15% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Laurus Labs Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Laurus Labs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.79%, the Debt to Equity ratio from the most recent quarter is 44.83, and its Gross Profit Margin stands at 60.94%.
- What is the recent revenue and earnings growth for LAURUSLABS?
- Looking at Laurus Labs's growth, its revenue over the trailing twelve months (TTM) was INR67B. Compared to the same quarter last year (YoY), quarterly revenue grew by 25.70%, and quarterly earnings saw a YoY growth of 172.70%.
- How much of LAURUSLABS stock is held by insiders and institutions?
- Wondering who owns Laurus Labs stock? Company insiders (like executives and directors) hold about 32.06% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 34.74%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.